Since its founding in 2004, the Australian owned and ASX listed SomnoMed has grown into one of the world’s most prominent and impactful medical device companies. Specialising in the development and manufacturing of instruments for the treatment of Obstructive Sleep Apnea (OSA), SommoMed has helped more than one million patients across 28 countries.
